4D Molecular Therapeutics Inc
(FDMT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 149,336 | 249,108 | 52,351 | 153,001 | 276,726 |
| Marketable Securities | 275,541 | 39,124 | 161,203 | 94,776 | N/A |
| Receivables | N/A | N/A | N/A | 47 | 1,486 |
| TOTAL | $434,932 | $296,588 | $220,511 | $256,280 | $282,656 |
| Non-Current Assets | |||||
| PPE Net | 19,534 | 20,126 | 22,262 | 14,391 | 5,073 |
| Investments And Advances | 80,583 | 10,954 | 4,908 | 67,652 | 0 |
| Other Non-Current Assets | 25,335 | 12,223 | 14,165 | 15,164 | 602 |
| TOTAL | $125,452 | $43,303 | $41,335 | $97,207 | $5,675 |
| Total Assets | $560,384 | $339,891 | $261,846 | $353,487 | $288,331 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,386 | 3,515 | 3,322 | 4,764 | 1,787 |
| Accrued Expenses | 18,869 | 12,014 | 8,870 | 7,744 | 8,371 |
| TOTAL | $29,149 | $18,951 | $15,731 | $16,338 | $16,744 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 257 | 273 | 884 | 2,599 | 6,586 |
| Other Non-Current Liabilities | 19,572 | 12,139 | 13,702 | 15,551 | 1,974 |
| TOTAL | $20,629 | $13,111 | $14,778 | $18,042 | $15,200 |
| Total Liabilities | $49,778 | $32,062 | $30,509 | $34,380 | $31,944 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,302 | 49,778 | 33,234 | 32,238 | N/A |
| Common Shares | 5 | 4 | 3 | 3 | 3 |
| Retained earnings | -576,195 | -415,327 | -314,490 | -206,996 | -135,679 |
| Other shareholders' equity | 229 | 16 | -1,196 | -423 | 0 |
| TOTAL | $510,606 | $307,829 | $231,337 | $319,107 | $256,387 |
| Total Liabilities And Equity | $560,384 | $339,891 | $261,846 | $353,487 | $288,331 |